Iron regulatory proteins: From molecular mechanisms to drug development

Antioxidants and Redox Signaling

Volumn 13, Issue 10, 2010, Pages 1593-1616

  Recalcati, Stefania ^a   Minotti, Giorgio ^b   Cairo, Gaetano ^a  

^a UNIVERSITY OF MILAN   (Italy)

^b UNIVERSITY CAMPUS BIO MEDICO   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

1,10 PHENANTHROLINE COPPER; ACETYLCYSTEINE; ANTHRACYCLINE; ANTIOXIDANT; BLEOMYCIN IRON; CARVEDILOL; COBALT DERIVATIVE; COBALT HEXAMMINE; DEFERIPRONE; HEPCIDIN; HYDRAZONE DERIVATIVE; IRON REGULATORY FACTOR; IRON REGULATORY FACTOR 1; IRON REGULATORY FACTOR 2; PYRIDOXAL 2 CHLOROBENZOYLHYDRAZONE; RAZOXANE; REACTIVE NITROGEN SPECIES; TEMPOL; UNCLASSIFIED DRUG; XENOBIOTIC AGENT;

CELL DAMAGE; CELL DEATH; CELL GROWTH; CELL METABOLISM; GENE EXPRESSION; HOMEOSTASIS; HUMAN; HYPOXIA; INTESTINE ABSORPTION; IRON ABSORPTION; IRON KINETICS; IRON METABOLISM; IRON RESPONSIVE ELEMENT; IRON STORAGE; IRON TRANSPORT; MACROPHAGE; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN STRUCTURE; REGULATORY MECHANISM; REVIEW; SINGLE NUCLEOTIDE POLYMORPHISM;

ANIMALS; DRUG DISCOVERY; HUMANS; IRON; IRON-REGULATORY PROTEINS; OXIDATIVE STRESS; REACTIVE NITROGEN SPECIES; XENOBIOTICS;

EUKARYOTA;

EID: 77954271890     PISSN: 15230864     EISSN: None     Source Type: Journal    
DOI: 10.1089/ars.2009.2983     Document Type: Review

References (233)

1. Aguilar-Martinez P, Schved JF, and Brissot P. The evaluation of hyperferritinemia: An updated strategy based on advances in detecting genetic abnormalities. Am J Gastro-enterol 100: 1185-1194, 2005.
2. Alberghini A, Recalcati S, Tacchini L, Santambrogio P, Campanella A, and Cairo G. Loss of the von Hippel Lindau tumor suppressor disrupts iron homeostasis in renal carcinoma cells. J Biol Chem 280: 30120-30128, 2005.
3. Anderson GJ, Frazer DM, and McLaren GD. Iron absorption and metabolism. Curr Opin Gastroenterol 25: 129-135, 2009.
4. Andrews NC. Forging a field: The golden age of iron biology. Blood 112: 219-230, 2008.
5. Arosio P, Adelman TG, and Drysdale JW. On ferritin heterogeneity. Further evidence for heteropolymers. J Biol Chem 253: 4451-4458, 1978.
6. Arosio P, Ingrassia R, and Cavadini P. Ferritins: A family of molecules for iron storage, antioxidation and more. Biochim Biophys Acta 1790: 589-599, 2009.
7. Beinert H and Kennedy MC. Aconitase, a two-faced protein: Enzyme and iron regulatory factor. FASEB J 7: 1442-1449, 1993.
8. Bianchi L, Tacchini L, and Cairo G. HIF-1-mediated activation of transferrin receptor gene transcription by iron chelation. Nucleic Acids Res 27: 4223-4227, 1999.
9. Brazzolotto X, Andriollo M, Guiraud P, Favier A, and Moulis JM. Interactions between doxorubicin and the human iron regulatory system. Biochim Biophys Acta 1593: 209-218, 2003.
10. Breuer W, Shvartsman M, and Cabantchik ZI. Intracellular labile iron. Int J Biochem Cell Biol 40: 350-354, 2008.
11. Cairo G, Bernuzzi F, and Recalcati S. A precious metal: Iron, an essential nutrient for all cells. Genes Nutr 1: 25-39, 2006.
12. Cairo G, Castrusini E, Minotti G, and Bernelli-Zazzera A. Superoxide and hydrogen peroxide-dependent inhibition of iron regulatory protein activity: A protective stratagem against oxidative injury. FASEB J 10: 1326-1335, 1996. (Pubitemid 26313536)
13. Cairo G and Pietrangelo A. Transferrin receptor gene expression during rat liver regeneration. Evidence for post-transcriptional regulation by iron regulatory factorB, a second iron-responsive element-binding protein. J Biol Chem 269: 6405-6409, 1994.
14. Cairo G and Pietrangelo A. Iron regulatory proteins in pathobiology. Biochem J 352 Pt 2: 241-250, 2000.
15. Cairo G and Recalcati S. Iron regulatory proteins: Molecular biology and pathophysiological implications. Expert Rev Mol Med 9: 1-13, 2007.
16. Cairo G, Recalcati S, Pietrangelo A, and Minotti G. The iron regulatory proteins: targets and modulators of free radical reactions and oxidative damage. Free Radic Biol Med 32: 1237-1243, 2002.
17. Cairo G, Ronchi R, Buccellato FR, Veber D, Santambrogio P, and Scalabrino G. Regulation of the ferritin H subunit by vitamin B12 (cobalamin) in rat spinal cord. J Neurosci Res 69: 117-124, 2002.
18. Cairo G, Tacchini L, Pogliaghi G, Anzon E, Tomasi A, and Bernelli-Zazzera A. Induction of ferritin synthesis by oxi-dative stress. Transcriptional and post-transcriptional regulation by expansion of the "free" iron pool. J Biol Chem 270: 700-703, 1995.
19. Caltagirone A, Weiss G, and Pantopoulos K. Modulation of cellular iron metabolism by hydrogen peroxide. Effects of H2O2 on the expression and function of iron-responsive element-containing mRNAs in B6 fibroblasts. J Biol Chem 276: 19738-19745, 2001.
20. Camaschella C. Understanding iron homeostasis through genetic analysis of hemochromatosis and related disorders. Blood 106: 3710-3717, 2005.
21. Canzoneri JC and Oyelere AK. Interaction of anthracyclines with iron responsive element mRNAs. Nucleic Acids Res 36: 6825-6834, 2008.
22. Cao W, McMahonM,WangB,O'ConnorR,and Clarkson M. A case report of spontaneous mutation (C33 >U) in the iron-responsive element of l-ferritin causing hyperferritinemia-cataract syndrome. Blood Cells Mol Dis 44: 22-27, 2010.
23. Cazzola M, Bergamaschi G, Tonon L, Arbustini E, Grasso M, Vercesi E, Barosi G, Bianchi PE, Cairo G, and Arosio P. Hereditary hyperferritinemia- cataract syndrome: Relationship between phenotypes and specific mutations in the iron-responsive element of ferritin light-chain mRNA. Blood 90: 814-821, 1997.
24. Chen G, Fillebeen C, Wang J, and Pantopoulos K. Over-expression of iron regulatory protein 1 suppresses growth of tumor xenografts. Carcinogenesis 28: 785-791, 2007.
25. Christova T and Templeton DM. Effect of hypoxia on the binding and subcellular distribution of iron regulatory proteins. Mol Cell Biochem 301: 21-32, 2007.
26. Church C, Lee S, Bagg EA, McTaggart JS, Deacon R, Ger-ken T, Lee A, Moir L, Mecinovic J, Quwailid MM, Schofield CJ, Ashcroft FM, and Cox RD. A mouse model for the metabolic effects of the human fat mass and obesity associated FTO gene. PLoS Genet 5: e1000599, 2009.
27. Cianetti L, Segnalini P, Calzolari A, Morsilli O, Felicetti F, Ramoni C, Gabbianelli M, Testa U, and Sposi NM. Expression of alternative transcripts of ferroportin-1 during human erythroid differentiation. Haematologica 90: 1595-1606, 2005.
28. Clarke SL, Vasanthakumar A, Anderson SA, Pondarre C, Koh CM, Deck KM, Pitula JS, Epstein CJ, Fleming MD, and Eisenstein RS. Iron-responsive degradation of iron-regulatory protein 1 does not require the Fe-S cluster. EMBO J 25: 544-553, 2006.
29. Cmejla R, Petrak J, and Cmejlova J. A novel iron responsive element in the 3'UTR of human MRCKalpha. Biochem Bio-phys Res Commun 341: 158-166, 2006.
30. Coffman LG, Parsonage D, D'Agostino R, Jr., Torti FM, and Torti SV. Regulatory effects of ferritin on angiogenesis. Proc Natl Acad Sci USA 106: 570-575, 2009.
31. Coon KD, Siegel AM, Yee SJ, Dunckley TL, Mueller C, Nagra RM, Tourtellotte WW, Reiman EM, Papassotir-opoulos A, Petersen FF, Stephan DA, and Kirsch WM. Preliminary demonstration of an allelic association of the IREB2 gene with Alzheimer's disease. J Alzheimers Dis 9: 225-233, 2006.
32. Cooperman SS, Meyron-Holtz EG, Olivierre-Wilson H, Ghosh MC, McConnell JP, and Rouault TA. Microcytic anemia, erythropoietic protoporphyria, and neurodegen-eration in mice with targeted deletion of iron-regulatory protein 2. Blood 106: 1084-1091, 2005.
33. Corna G, Galy B, Hentze MW, and Cairo G. IRP1-inde-pendent alterations of cardiac iron metabolism in doxoru-bicin-treated mice. J Mol Med 84: 551-560, 2006.
34. Corna G, Santambrogio P, Minotti G, and Cairo G. Dox-orubicin paradoxically protects cardiomyocytes against iron-mediated toxicity: Role of reactive oxygen species and ferritin. J Biol Chem 279: 13738-13745, 2004.
35. Cox TC, Bawden MJ, Martin A, and May BK. Human erythroid 5-aminolevulinate synthase: Promoter analysis and identification of an iron-responsive element in the mRNA. EMBO J 10: 1891-1902, 1991.
36. Cozzi A, Corsi B, Levi S, Santambrogio P, Albertini A, and Arosio P. Overexpression of wild type and mutated human ferritin H-chain in HeLa cells: In vivo role of fer-ritin ferroxidase activity. J Biol Chem 275: 25122-25129, 2000.
37. Cremonesi L, Foglieni B, Fermo I, Cozzi A, Paroni R, Ruggeri G, Belloli S, Levi S, Fargion S, Ferrari M, and Arosio P. Identification of two novel mutations in the 5'-untranslated region of H-ferritin using denaturing high performance liquid chromatography scanning. Haematolo-gica 88: 1110-1116, 2003.
38. Crooks DR, Ghosh MC, Haller RG, Tong WH, and Rouault TA. Post-translational stability of the heme biosynthetic enzyme ferrochelatase is dependent on iron availability and intact iron-sulfur cluster assembly machinery. Blood 115: 860-869, 2010.
39. Dandekar T, Stripecke R, Gray NK, Goossen B, Constable A, Johansson HE, and Hentze MW. Identification of a novel iron-responsive element in murine and human erythroid delta-aminolevulinic acid synthase mRNA. EMBO J 10: 1903-1909, 1991.
40. De Domenico I, McVey Ward D, and Kaplan J. Regulation of iron acquisition and storage: Consequences for iron-linked disorders. Nat Rev Mol Cell Biol 9: 72-81, 2008.
41. De Domenico I, Ward DM, Nemeth E, Vaughn MB, Musci G, Ganz T, and Kaplan J. The molecular basis of ferro-portin-linked hemochromatosis. Proc Natl Acad Sci USA 102: 8955-8960, 2005.
42. Deck KM, Vasanthakumar A, Anderson SA, Goforth JB, Kennedy MC, Antholine WE, and Eisenstein RS. Evidence that phosphorylation of iron regulatory protein 1 at Serine 138 destabilizes the [4Fe-4S] cluster in cytosolic aconitase by enhancing 4Fe-3Fe cycling. J Biol Chem 284: 12701-12709, 2009.
43. Delaby C, Pilard N, Puy H, and Canonne-Hergaux F. Sequential regulation of ferroportin expression after ery-throphagocytosis in murine macrophages: Early mRNA induction by haem, followed by iron-dependent protein expression. Biochem J 411: 123-131, 2008.
44. DeMeo DL, Mariani T, Bhattacharya S, Srisuma S, Lange C, Litonjua A, Bueno R, Pillai SG, Lomas DA, Sparrow D, Shapiro SD, Criner GJ, Kim HP, Chen Z, Choi AM, Reilly J, and Silverman EK. Integration of genomic and genetic approaches implicates IREB2 as a COPD susceptibility gene. Am J Hum Genet 85: 493-502, 2009.
45. Donovan A, Lima CA, Pinkus JL, Pinkus GS, Zon LI, Ro-bine S, and Andrews NC. The iron exporter ferro-portin=Slc40a1 is essential for iron homeostasis. Cell Metab 1: 191-200, 2005.
46. Dos Santos CO, Dore LC, Valentine E, Shelat SG, Hardison RC, Ghosh M, Wang W, Eisenstein RS, Costa FF, and Weiss MJ. An iron responsive element-like stem-loop regulates alpha-hemoglobin-stabilizing protein mRNA. J Biol Chem 283: 26956-26964, 2008.
47. Drakesmith H and Prentice A. Viral infection and iron metabolism. Nat Rev Microbiol 6: 541-552, 2008.
48. Drapier JC. Interplay between NO and [Fe-S] clusters: Relevance to biological systems. Methods 11: 319-329, 1997.
49. Dupuy J, Volbeda A, Carpentier P, Darnault C, Moulis JM, and Fontecilla-Camps JC. Crystal structure of human iron regulatory protein 1 as cytosolic aconitase. Structure 14: 129-139, 2006. (Pubitemid 43350080)
50. Dycke C, Bougault C, Gaillard J, Andrieu JP, Pantopoulos K, and Moulis JM. Human iron regulatory protein 2 is easily cleaved in its specific domain: Consequences for the haem binding properties of the protein. Biochem J 408: 429-439, 2007.
51. Dycke C, Charbonnier P, Pantopoulos K, and Moulis JM. A role for lysosomes in the turnover of human iron regulatory protein 2. Int J Biochem Cell Biol 40: 2826-2832, 2008.
52. Epsztejn S, Glickstein H, Picard V, Slotki IN, Breuer W, Beaumont C, and Cabantchik ZI. H-ferritin subunit over-expression in erythroid cells reduces the oxidative stress response and induces multidrug resistance properties. Blood 94: 3593-3603, 1999.
53. Faucheux BA, Martin ME, Beaumont C, Hunot S, Hauw JJ, Agid Y, and Hirsch EC. Lack of up-regulation of ferritin is associated with sustained iron regulatory protein-1 binding activity in the substantia nigra of patients with Parkinson's disease. J Neurochem 83: 320-330, 2002.
54. Ferring-Appel D, Hentze MW, and Galy B. Cell-autonomous and systemic context-dependent functions of iron regulatory protein 2 in mammalian iron metabolism. Blood 113: 679-687, 2009.
55. Festa M, Ricciardelli G, Mele G, Pietropaolo C, Ruffo A, and Colonna A. Overexpression of H ferritin and up-regulation of iron regulatory protein genes during differentiation of 3T3-L1 pre-adipocytes. J Biol Chem 275: 36708-36712, 2000.
56. Fillebeen C, Muckenthaler M, Andriopoulos B, Bisaillon M, Mounir Z, Hentze MW, Koromilas AE, and Pantopoulos K. Expression of the subgenomic hepatitis C virus replicon alters iron homeostasis in Huh7 cells. J Hepatol 47: 12-22, 2007.
57. Florenzano F and Salman P. Carvedilol for anthracycline cardiomyopathy prevention. J Am Coll Cardiol 49: 2142; author reply 2142-2143, 2007.
58. Friedlich AL, Tanzi RE, and Rogers JT. The 5'-untranslated region of Parkinson's disease alpha-synuclein messen-gerRNA contains a predicted iron responsive element. Mol Psychiatry 12: 222-223, 2007.
59. Fuchs J, Podda M, Packer L, and Kaufmann R. Morbidity risk in HFE associated hereditary hemochromatosis C282Y heterozygotes. Toxicology 180: 169-181, 2002.
60. Galy B, Ferring-Appel D, Kaden S, Grone HJ, and Hentze MW. Iron regulatory proteins are essential for intestinal function and control key iron absorption molecules in the duodenum. Cell Metab 7: 79-85, 2008.
61. Galy B, Ferring D, Minana B, Bell O, Janser HG, Muck-enthaler M, Schumann K, and Hentze MW. Altered body iron distribution and microcytosis in mice deficient in iron regulatory protein 2 (IRP2). Blood 106: 2580-2589, 2005.
62. Galy B, Holter SM, Klopstock T, Ferring D, Becker L, Kaden S, Wurst W, Grone HJ, and Hentze MW. Iron homeostasis in the brain: Complete iron regulatory protein 2 deficiency without symptomatic neurodegeneration in the mouse. Nat Genet 38: 967-969; discussion 969-970, 2006.
63. Gehring NH, Hentze MW, and Pantopoulos K. Inactivation of both RNA binding and aconitase activities of iron regulatory protein-1 by quinone-induced oxidative stress. J Biol Chem 274: 6219-6225, 1999.
64. Ghosh M, Ollivierre-Wilson H, Cooperman S, and Rouault T. Reply to "Iron homeostasis in the brain: complete iron regulatory protein 2 deficiency without symptomatic neu-rodegeneration in the mouse". Nat Gen 38: 969-970, 2006.
65. Ghosh MC, Tong WH, Zhang D, Ollivierre-Wilson H, Singh A, Krishna MC, Mitchell JB, and Rouault TA. Tem-pol-mediated activation of latent iron regulatory protein activity prevents symptoms of neurodegenerative disease in IRP2 knockout mice. Proc Natl Acad Sci USA 105: 12028-12033, 2008.
66. Gianni L, Herman EH, Lipshultz SE, Minotti G, Sarvazyan N, and Sawyer DB. Anthracycline cardiotoxicity: From bench to bedside. J Clin Oncol 26: 3777-3784, 2008.
67. Goforth JB, Anderson SA, Nizzi CP, and Eisenstein RS. Multiple determinants within iron-responsive elements dictate iron regulatory protein binding and regulatory hierarchy. RNA 16: 154-169, 2010.
68. Gray NK, Pantopoulos K, Dandekar T, Ackrell BA, and Hentze MW. Translational regulation of mammalian and Drosophila citric acid cycle enzymes via iron-responsive elements. Proc Natl Acad Sci USA 93: 4925-4930, 1996.
69. Gu JM, Lim SO, Oh SJ, Yoon SM, Seong JK, and Jung G. HBx modulates iron regulatory protein 1-mediated iron metabolism via reactive oxygen species. Virus Res 133: 167-177, 2008.
70. Guo B, Phillips JD, Yu Y, and Leibold EA. Iron regulates the intracellular degradation of iron regulatory protein 2 by the proteasome. J Biol Chem 270: 21645-21651, 1995.
71. Guo B, Yu Y, Leibold EA. Iron regulates cytoplasmic levels of a novel iron-responsive element-binding protein without aconitase activity. J Biol Chem 269: 24252-24260, 1994.
72. Hajdusek O, Sojka D, Kopacek P, Buresova V, Franta Z, Sauman I, Winzerling J, and Grubhoffer L. Knockdown of proteins involved in iron metabolism limits tick reproduction and development. Proc Natl Acad Sci USA 106: 1033-1038, 2009.
73. Halliwell B. Biochemistry of oxidative stress. Biochem Soc Trans 35: 1147-1150, 2007.
74. Hanson ES, Foot LM, and Leibold EA. Hypoxia post-translationally activates iron-regulatory protein 2. J Biol Chem 274: 5047-5052, 1999.
75. Hanson ES, Rawlins ML, and Leibold EA. Oxygen and iron regulation of iron regulatory protein 2. J Biol Chem 278: 40337-40342, 2003.
76. Harrison PM and Arosio P. The ferritins: Molecular properties, iron storage function and cellular regulation. Biochim Biophys Acta 1275: 161-203, 1996.
77. Hasinoff BB and Herman EH. Dexrazoxane: How it works in cardiac and tumor cells. Is it a prodrug or is it a drug? Cardiovasc Toxicol 7: 140-144, 2007.
78. Hentze MW and Kuhn LC. Molecular control of vertebrate iron metabolism: mRNA-based regulatory circuits operated by iron, nitric oxide, and oxidative stress. Proc Natl Acad Sci USA 93: 8175-8182, 1996.
79. Hentze MW, Rouault TA, Harford JB, and Klausner RD. Oxidation-reduction and the molecular mechanism of a regulatory RNA-protein interaction. Science 244: 357-379, 1989.
80. Hirling H, Henderson BR, and Kuhn LC. Mutational analysis of the [4Fe-4S]-cluster converting iron regulatory factor from its RNA-binding form to cytoplasmic aconitase. EMBO J 13: 453-461, 1994.
81. Hower V, Mendes P, Torti FM, Laubenbacher R, Akman S, Shulaev V, and Torti SV. A general map of iron metabolism and tissue-specific subnetworks. Mol Biosyst 5: 422-443, 2009.
82. Irace C, Scorziello A, Maffettone C, Pignataro G, Matrone C, Adornetto A, Santamaria R, Annunziato L, and Colonna A. Divergent modulation of iron regulatory proteins and ferritin biosynthesis by hypoxia=reoxygenation in neurones and glial cells. J Neurochem 95: 1321-1331, 2005.
83. Ishii KA, Fumoto T, Iwai K, Takeshita S, Ito M, Shimohata N, Aburatani H, Taketani S, Lelliott CJ, Vidal-Puig A, and Ikeda K. Coordination of PGC-1beta and iron uptake in mitochondrial biogenesis and osteoclast activation. Nat Med 15: 259-266, 2009.
84. Ishikawa H, Kato M, Hori H, Ishimori K, Kirisako T, To-kunaga F, and Iwai K. Involvement of heme regulatory motif in heme-mediated ubiquitination and degradation of IRP2. Mol Cell 19: 171-181, 2005.
85. Iwai K, Drake SK, Wehr NB, Weissman AM, LaVaute T, Minato N, Klausner RD, Levine RL, and Rouault TA. Iron-dependent oxidation, ubiquitination, and degradation of iron regulatory protein 2: Implications for degradation of oxidized proteins. Proc Natl Acad Sci USA 95: 4924-4928, 1998.
86. Iwai K, Klausner RD, and Rouault TA. Requirements for iron-regulated degradation of the RNA binding protein, iron regulatory protein 2. EMBO J 14: 5350-5357, 1995.
87. Iyer LM, Tahiliani M, Rao A, and Aravind L. Prediction of novel families of enzymes involved in oxidative and other complex modifications of bases in nucleic acids. Cell Cycle 8: 1698-1710, 2009.
88. Kalay N, Basar E, Ozdogru I, Er O, Cetinkaya Y, Dogan A, Inanc T, Oguzhan A, Eryol NK, Topsakal R, and Ergin A. Protective effects of carvedilol against anthracycline-induced cardiomyopathy. J Am Coll Cardiol 48: 2258-2262, 2006.
89. Kato J, Fujikawa K, Kanda M, Fukuda N, Sasaki K, Ta-kayama T, Kobune M, Takada K, Takimoto R, Hamada H, Ikeda T, and Niitsu Y. A mutation, in the iron-responsive element of H ferritin mRNA, causing autosomal dominant iron overload. Am J Hum Genet 69: 191-197, 2001.
90. Ke Y, Wu J, Leibold EA, Walden WE, and Theil EC. Loops and bulge=loops in iron-responsive element isoforms influence iron regulatory protein binding. Fine-tuning of mRNA regulation? J Biol Chem 273: 23637-23640, 1998.
91. Keel SB, Doty RT, Yang Z, Quigley JG, Chen J, Knoblaugh S, Kingsley PD, De Domenico I, Vaughn MB, Kaplan J, Palis J, and Abkowitz JL. A heme export protein is required for red blood cell differentiation and iron homeostasis. Science 319: 825-828, 2008.
92. Kennedy MC, Mende-Mueller L, Blondin GA, and Beinert H. Purification and characterization of cytosolic aconitase from beef liver and its relationship to the iron-responsive element binding protein. Proc Natl Acad Sci USA 89: 11730-11734, 1992.
93. Kerenyi MA, Grebien F, Gehart H, Schifrer M, Artaker M, Kovacic B, Beug H, Moriggl R, and Mullner EW. Stat5 regulates cellular iron uptake of erythroid cells via IRP-2 and TfR-1. Blood 112: 3878-3888, 2008.
94. Khan MA, Walden WE, Goss DJ, and Theil EC. Direct Fe2\+sensing by iron responsive messenger RNA=repres-sor complexes weakens binding. J Biol Chem 284: 30122-30128, 2009.
95. Kiemer AK, Fornges AC, Pantopoulos K, Bilzer M, An-driopoulos B, Gerwig T, Kenngott S, Gerbes AL, and Vollmar AM. ANP-induced decrease of iron regulatory protein activity is independent of HO-1 induction. Am J Physiol Gastrointest Liver Physiol 287: G518-526, 2004.
96. Kim BH, Jun YC, Jin JK, Kim JI, Kim NH, Leibold EA, Connor JR, Choi EK, Carp RI, and Kim YS. Alteration of iron regulatory proteins (IRP1 and IRP2) and ferritin in the brains of scrapie-infected mice. Neurosci Lett 422: 158-163, 2007.
97. Kim S and Ponka P. Effects of interferon-gamma and li-popolysaccharide on macrophage iron metabolism are mediated by nitric oxide-induced degradation of iron regulatory protein 2. J Biol Chem 275: 6220-6226, 2000.
98. Kim S and Ponka P. Nitric oxide-mediated modulation of iron regulatory proteins: implication for cellular iron ho-meostasis. Blood Cells Mol Dis 29: 400-410, 2002.
99. Kohler SA, Henderson BR, and Kuhn LC. Succinate dehy-drogenase b mRNA of Drosophila melanogaster has a functional iron-responsive element in its 5'-untranslated region. J Biol Chem 270: 30781-30786, 1995.
100. Kohler SA, Menotti E, and Kuhn LC. Molecular cloning of mouse glycolate oxidase. High evolutionary conservation and presence of an iron-responsive element-like sequence in the mRNA. J Biol Chem 274: 2401-2407, 1999.
101. Kwok JC and Richardson DR. Unexpected anthracycline-mediated alterations in iron-regulatory protein-RNA-binding activity: The iron and copper complexes of an-thracyclines decrease RNA-binding activity. Mol Pharmacol 62: 888-900, 2002.
102. Ladas EJ, Jacobson JS, Kennedy DD, Teel K, Fleischauer A, and Kelly KM. Antioxidants and cancer therapy: A systematic review. J Clin Oncol 22: 517-528, 2004.
103. Lakhal S, Talbot NP, Crosby A, Stoepker C, Townsend AR, Robbins PA, Pugh CW, Ratcliffe PJ, and Mole DR. Regulation of growth differentiation factor 15 expression by intracellular iron. Blood 113: 1555-1563, 2009.
104. Latunde-Dada GO, Takeuchi K, Simpson RJ, and McKie AT. Haem carrier protein 1 (HCP1): Expression and functional studies in cultured cells. FEBS Lett 580: 6865-6870, 2006.
105. LaVaute T, Smith S, Cooperman S, Iwai K, Land W, Meyron-Holtz E, Drake SK, Miller G, Abu-Asab M, Tsokos M, Switzer R, 3rd, Grinberg A, Love P, Tresser N, and Rouault TA. Targeted deletion of the gene encoding iron regulatory protein-2 causes misregulation of iron metabolism and neurodegenerative disease in mice. Nat Genet 27: 209-214, 2001.
106. Lee PJ, Jiang BH, Chin BY, Iyer NV, Alam J, Semenza GL, and Choi AM. Hypoxia-inducible factor-1 mediates transcriptional activation of the heme oxygenase-1 gene in response to hypoxia. J Biol Chem 272: 5375-5381, 1997.
107. Leedman PJ, Stein AR, Chin WW, and Rogers JT. Thyroid hormone modulates the interaction between iron regulatory proteins and the ferritin mRNA iron-responsive element. J Biol Chem 271: 12017-12023, 1996.
108. Leipuviene R and Theil EC. The family of iron responsive RNA structures regulated by changes in cellular iron and oxygen. Cell Mol Life Sci 64: 2945-2955, 2007.
109. Levi S and Arosio P. Mitochondrial ferritin. Int J Biochem Cell Biol 36: 1887-1889, 2004.
110. Li Z, Chen-Roetling J, and Regan RF. Increasing expression of H-or L-ferritin protects cortical astrocytes from hemin toxicity. Free Radic Res 43: 613-621, 2009.
111. Lill R. Function and biogenesis of iron-sulphur proteins. Nature 460: 831-838, 2009.
112. Liu W, Shimomura S, Imanishi H, Iwamoto Y, Ikeda N, Saito M, Ohno M, Hara N, Yamamoto T, Nakamura H, and Hada T. Hemochromatosis with mutation of the ferroportin 1 (IREG1) gene. Intern Med 44: 285-289, 2005.
113. Liu XB, Hill P, and Haile DJ. Role of the ferroportin iron-responsive element in iron and nitric oxide dependent gene regulation. Blood Cells Mol Dis 29: 315-326, 2002.
114. Liu YL, Ang SO, Weigent DA, Prchal JT, and Bloomer JR. Regulation of ferrochelatase gene expression by hypoxia. Life Sci 75: 2035-2043, 2004.
115. Lok CN and Ponka P. Identification of a hypoxia response element in the transferrin receptor gene. J Biol Chem 274: 24147-24152, 1999.
116. Lymboussaki A, Pignatti E, Montosi G, Garuti C, Haile DJ, and Pietrangelo A. The role of the iron responsive element in the control of ferroportin1=IREG1=MTP1 gene expression. J Hepatol 39: 710-715, 2003.
117. Lyu YL, Kerrigan JE, Lin CP, Azarova AM, Tsai YC, Ban Y, and Liu LF. Topoisomerase IIbeta mediated DNA double-strand breaks: implications in doxorubicin cardiotoxicity and prevention by dexrazoxane. Cancer Res 67: 8839-8846, 2007.
118. Mackenzie B and Garrick MD. Iron Imports. II. Iron uptake at the apical membrane in the intestine. Am J Physiol Gas-trointest Liver Physiol 289: G981-986, 2005.
119. MacKenzie EL, Iwasaki K, and Tsuji Y. Intracellular iron transport and storage: From molecular mechanisms to health implications. Antioxid Redox Signal 10: 997-1030, 2008.
120. Maffettone C, De Martino L, Irace C, Santamaria R, Pagnini U, Iovane G, and Colonna A. Expression of iron-related proteins during infection by bovine herpes virus type-1. J Cell Biochem 104: 213-223, 2008.
121. Mastrogiannaki M, Matak P, Keith B, Simon MC, Vaulont S, and Peyssonnaux C. HIF-2alpha, but not HIF-1alpha, promotes iron absorption in mice. J Clin Invest 119: 1159-1166, 2009.
122. Mattace Raso G, Irace C, Esposito E, Maffettone C, Iacono A, Di Pascale A, Santamaria R, Colonna A, and Meli R. Ovariectomy and estrogen treatment modulate iron metabolism in rat adipose tissue. Biochem Pharmacol 78: 1001-1007, 2009.
123. McKie AT. The role of Dcytb in iron metabolism: An update. Biochem Soc Trans 36: 1239-1241, 2008.
124. McKie AT, Marciani P, Rolfs A, Brennan K, Wehr K, Barrow D, Miret S, Bomford A, Peters TJ, Farzaneh F, Hediger MA, Hentze MW, and Simpson RJ. A novel duodenal iron-regulated transporter, IREG1, implicated in the basolateral transfer of iron to the circulation. Mol Cell 5: 299-309, 2000.
125. McMahon S, Grondin F, McDonald PP, Richard DE, and Dubois CM. Hypoxia-enhanced expression of the propro-tein convertase furin is mediated by hypoxia-inducible factor-1: Impact on the bioactivation of proproteins. J Biol Chem 280: 6561-6569, 2005.
126. Menna P, Salvatorelli E, Gianni L, and Minotti G. Antra-cycline cardiotoxicity Top Curr Chem 283: 21-44, 2008.
127. Menna P, Salvatorelli E, and Minotti G. Cardiotoxicity of antitumor drugs. Chem Res Toxicol 21: 978-989, 2008.
128. Meyron-Holtz EG, Ghosh MC, and Rouault TA. Mammalian tissue oxygen levels modulate iron-regulatory protein activities in vivo. Science 306: 2087-2090, 2004.
129. Minotti G, Cairo G, and Monti E. Role of iron in anthra-cycline cardiotoxicity: New tunes for an old song? FASEB J 13: 199-212, 1999.
130. Minotti G, Licata S, Saponiero A, Menna P, Calafiore AM, Di Giammarco G, Liberi G, Animati F, Cipollone A, Manzini S, and Maggi CA. Anthracycline metabolism and toxicity in human myocardium: Comparisons between doxorubicin, epirubicin, and a novel disaccharide analogue with a reduced level of formation and [4Fe-4S] reactivity of its secondary alcohol metabolite. Chem Res Toxicol 13: 1336-1341, 2000.
131. Minotti G, Menna P, Salvatorelli E, Cairo G, and Gianni L. Anthracyclines: Molecular advances and pharmacologic developments in antitumor activity and cardiotoxicity. Pharmacol Rev 56: 185-229, 2004.
132. Minotti G, Parlani M, Salvatorelli E, Menna P, Cipollone A, Animati F, Maggi CA, and Manzini S. Impairment of myocardial contractility by anticancer anthracyclines: Role of secondary alcohol metabolites and evidence of reduced toxicity by a novel disaccharide analogue. Br J Pharmacol 134: 1271-1278, 2001.
133. Minotti G, Recalcati S, Mordente A, Liberi G, Calafiore AM, Mancuso C, Preziosi P, and Cairo G. The secondary alcohol metabolite of doxorubicin irreversibly inactivates aconita-se=iron regulatory protein-1 in cytosolic fractions from human myocardium. FASEB J 12: 541-552, 1998.
134. Minotti G, Ronchi R, Salvatorelli E, Menna P, and Cairo G. Doxorubicin irreversibly inactivates iron regulatory proteins 1 and 2 in cardiomyocytes: Evidence for distinct metabolic pathways and implications for iron-mediated cardiotoxicity of antitumor therapy. Cancer Res 61: 8422-8428, 2001.
135. Mok H, Jelinek J, Pai S, Cattanach BM, Prchal JT, Yous-soufian H, and Schumacher A. Disruption of ferroportin 1 regulation causes dynamic alterations in iron homeostasis and erythropoiesis in polycythaemia mice. Development 131: 1859-1868, 2004.
136. Mole DR. Iron homeostasis and its interaction with prolyl hydroxylases. Antioxid Redox Signal 12: 445-458, 2010.
137. Muckenthaler M, Gunkel N, Frishman D, Cyrklaff A, Tomancak P, and Hentze MW. Iron-regulatory protein-1 (IRP-1) is highly conserved in two invertebrate species\-Characterization of IRP-1 homologues in Drosophila mela-nogaster and Caenorhabditis elegans. Eur J Biochem 254: 230-237, 1998.
138. Muckenthaler MU, Galy B, and Hentze MW. Systemic iron homeostasis and the iron-responsive element=iron-regulatory protein (IRE=IRP) regulatory network. Annu Rev Nutr 28: 197-213, 2008.
139. Mueller C, Magaki S, Schrag M, Ghosh MC, and Kirsch WM. Iron regulatory protein 2 is involved in brain copper homeostasis. J Alzheimers Dis 18: 201-210, 2009.
140. Mukhopadhyay CK, Mazumder B, and Fox PL. Role of hypoxia-inducible factor-1 in transcriptional activation of ceruloplasmin by iron deficiency. J Biol Chem 275: 21048-21054, 2000.
141. Nairz M, Theurl I, Ludwiczek S, Theurl M, Mair SM, Fritsche G, and Weiss G. The co-ordinated regulation of iron homeostasis in murine macrophages limits the availability of iron for intracellular Salmonella typhimurium. Cell Microbiol 9: 2126-2140, 2007.
142. Nemeth E and Ganz T. Regulation of iron metabolism by hepcidin. Annu Rev Nutr 26: 323-342, 2006.
143. Nemeth E, Tuttle MS, Powelson J, Vaughn MB, Donovan A, Ward DM, Ganz T, and Kaplan J. Hepcidin regulates cellular iron efflux by binding to ferroportin and inducing its internalization. Science 306: 2090-2093, 2004.
144. Nicolas G, Chauvet C, Viatte L, Danan JL, Bigard X, De-vaux I, Beaumont C, Kahn A, and Vaulont S. The gene encoding the iron regulatory peptide hepcidin is regulated by anemia, hypoxia, and inflammation. J Clin Invest 110: 1037-1044, 2002.
145. Nurtjahja-Tjendraputra E, Fu D, Phang JM, and Richardson DR. Iron chelation regulates cyclin D1 expression via the proteasome: A link to iron deficiency-mediated growth suppression. Blood 109: 4045-4054, 2007.
146. O'Donnell KA, Yu D, Zeller KI, Kim JW, Racke F, Thomas-Tikhonenko A, and Dang CV. Activation of transferrin receptor 1 by c-Myc enhances cellular proliferation and tumorigenesis. Mol Cell Biol 26: 2373-2386, 2006.
147. Oktay Y, Dioum E, Matsuzaki S, Ding K, Yan LJ, Haller RG, Szweda LI, and Garcia JA. Hypoxia-inducible factor 2alpha regulates expression of the mitochondrial aconitase chaperone protein frataxin. J Biol Chem 282: 11750-11756, 2007.
148. Oliveira L and Drapier JC. Down-regulation of iron regulatory protein 1 gene expression by nitric oxide. Proc Natl Acad Sci USA 97: 6550-6555, 2000.
149. Oliveira SJ, Pinto JP, Picarote G, Costa VM, Carvalho F, Rangel M, de Sousa M, and de Almeida SF. ER stress-inducible factor CHOP affects the expression of hepcidin by modulating C/EBPalpha activity. PLoS One 4: e6618, 2009.
150. Orino K, Lehman L, Tsuji Y, Ayaki H, Torti SV, and Torti FM. Ferritin and the response to oxidative stress. Biochem J 357: 241-247, 2001.
151. Patton SM, Pinero DJ, Surguladze N, Beard J, and Connor JR. Subcellular localization of iron regulatory proteins to Golgi and ER membranes. J Cell Sci 118: 4365-4373, 2005.
152. Peyssonnaux C, Nizet V, and Johnson RS. Role of the hypoxia inducible factors HIF in iron metabolism. Cell Cycle 7: 28-32, 2008.
153. Peyssonnaux C, Zinkernagel AS, Schuepbach RA, Rankin E, Vaulont S, Haase VH, Nizet V, and Johnson RS. Regulation of iron homeostasis by the hypoxia-inducible tran scription factors (HIFs). J Clin Invest 117: 1926-1932, 2007.
154. Piccinelli P and Samuelsson T. Evolution of the iron-responsive element. RNA 13: 952-966, 2007.
155. Pietrangelo A. Hereditary hemochromatosis\-A new look at an old disease. N Engl J Med 350: 2383-2397, 2004.
156. Popelova O, Sterba M, Simunek T, Mazurova Y, Guncova I, Hroch M, Adamcova M, and Gersl V. Deferiprone does not protect against chronic anthracycline cardiotoxicity in vivo. J Pharmacol Exp Ther 326: 259-269, 2008.
157. Qiu A, Jansen M, Sakaris A, Min SH, Chattopadhyay S, Tsai E, Sandoval C, Zhao R, Akabas MH, and Goldman ID. Identification of an intestinal folate transporter and the molecular basis for hereditary folate malabsorption. Cell 127: 917-928, 2006.
158. Quigley JG, Yang Z, Worthington MT, Phillips JD, Sabo KM, Sabath DE, Berg CL, Sassa S, Wood BL, and Abkowitz JL. Identification of a human heme exporter that is essential for erythropoiesis. Cell 118: 757-766, 2004.
159. Recalcati S, Alberghini A, Campanella A, Gianelli U, De Camilli E, Conte D, and Cairo G. Iron regulatory proteins 1 and 2 in human monocytes, macrophages and duodenum: Expression and regulation in hereditary hemochromatosis and iron deficiency. Haematologica 91: 303-310, 2006.
160. Recalcati S, Conte D, and Cairo G. Preferential activation of iron regulatory protein-2 in cell lines as a result of higher sensitivity to iron. Eur J Biochem 259: 304-309, 1999.
161. Recalcati S, Invernizzi P, Arosio P, and Cairo G. New functions for an iron storage protein: The role of ferritin in immunity and autoimmunity. J Autoimmun 30: 84-89, 2008.
162. Recalcati S, Locati M, Marini A, Santambrogio P, Zaninotto F, De Pizzol M, Zammataro L, Girelli D, and Cairo G. Differential regulation of iron homeostasis during human macrophage polarized activation. Eur J Immunol 40: 824-835, 2010.
163. Recalcati S, Pometta R, Levi S, Conte D, and Cairo G. Response of monocyte iron regulatory protein activity to inflammation: Abnormal behavior in genetic hemochroma-tosis. Blood 91: 2565-2572, 1998.
164. Recalcati S, Tacchini L, Alberghini A, Conte D, and Cairo G. Oxidative stress-mediated down-regulation of rat hy-droxyacid oxidase 1, a liver-specific peroxisomal enzyme. Hepatology 38: 1159-1166, 2003.
165. Recalcati S, Taramelli D, Conte D, and Cairo G. Nitric oxide-mediated induction of ferritin synthesis in J774 macrophages by inflammatory cytokines: Role of selective iron regulatory protein-2 downregulation. Blood 91: 1059-1066, 1998.
166. Robach P, Cairo G, Gelfi C, Bernuzzi F, Pilegaard H, Vig-ano A, Santambrogio P, Cerretelli P, Calbet JA, Moutereau S, and Lundby C. Strong iron demand during hypoxia-induced erythropoiesis is associated with down-regulation of iron-related proteins and myoglobin in human skeletal muscle. Blood 109: 4724-4731, 2007.
167. Robach P, Recalcati S, Girelli D, Gelfi C, Aachmann-Andersen NJ, Thomsen JJ, Norgaard AM, Alberghini A, Campostrini N, Castagna A, Vigano A, Santambrogio P, Kempf T, Wollert KC, Moutereau S, Lundby C, and Cairo G. Alterations of systemic and muscle iron metabolism in human subjects treated with low-dose recombinant eryth-ropoietin. Blood 113: 6707-6715, 2009.
168. Rogers JT, Bush AI, Cho HH, Smith DH, Thomson AM, Friedlich AL, Lahiri DK, Leedman PJ, Huang X, and Cahill CM. Iron and the translation of the amyloid precursor protein (APP) and ferritin mRNAs: Riboregulation against neural oxidative damage in Alzheimer's disease. Biochem Soc Trans 36: 1282-1287, 2008.
169. Rogers JT, Randall JD, Cahill CM, Eder PS, Huang X, Gunshin H, Leiter L, McPhee J, Sarang SS, Utsuki T, Greig NH, Lahiri DK, Tanzi RE, Bush AI, Giordano T, and Gullans SR. An iron-responsive element type II in the 5'-untranslated region of the Alzheimer's amyloid precursor protein transcript. J Biol Chem 277: 45518-45528, 2002.
170. Rolfs A, Kvietikova I, Gassmann M, and Wenger RH. Oxygen-regulated transferrin expression is mediated by hypoxia-inducible factor-1. J Biol Chem 272: 20055-20062, 1997.
171. Rothenberger S, Mullner EW, and Kuhn LC. The mRNA-binding protein which controls ferritin and transferrin receptor expression is conserved during evolution. Nucleic Acids Res 18: 1175-1179, 1990.
172. Rouault TA. The role of iron regulatory proteins in mammalian iron homeostasis and disease. Nat Chem Biol 2: 406-414, 2006.
173. Salahudeen AA, Thompson JW, Ruiz JC, Ma HW, Kinch LN, Li Q, Grishin NV, and Bruick RK. An E3 ligase possessing an iron responsive hemerythrin domain is a regulator of iron homeostasis. Science 326: 722-726, 2009.
174. Samaniego F, Chin J, Iwai K, Rouault TA, and Klausner RD. Molecular characterization of a second iron-responsive element binding protein, iron regulatory protein 2. Structure, function, and post-translational regulation. J Biol Chem 269: 30904-30910, 1994.
175. Sammarco MC, Ditch S, Banerjee A, and Grabczyk E. Fer-ritin L and H subunits are differentially regulated on a post-transcriptional level. J Biol Chem 283: 4578-4587, 2008.
176. Sanchez M, Galy B, Dandekar T, Bengert P, Vainshtein Y, Stolte J, Muckenthaler MU, and Hentze MW. Iron regula-tion and the cell cycle: Identification of an iron-responsive element in the 3'-untranslated region of human cell division cycle 14A mRNA by a refined microarray-based screening strategy. J Biol Chem 281: 22865-22874, 2006.
177. Sanchez M, Galy B, Muckenthaler MU, and Hentze MW. Iron-regulatory proteins limit hypoxia-inducible factor-2alpha expression in iron deficiency. Nat Struct Mol Biol 14: 420-426, 2007.
178. Schalinske KL, Blemings KP, Steffen DW, Chen OS, and Eisenstein RS. Iron regulatory protein 1 is not required for the modulation of ferritin and transferrin receptor expression by iron in a murine pro-B lymphocyte cell line. Proc Natl Acad Sci USA 94: 10681-10686, 1997.
179. Schalinske KL, Chen OS, and Eisenstein RS. Iron differentially stimulates translation of mitochondrial aconitase and ferritin mRNAs in mammalian cells. Implications for iron regulatory proteins as regulators of mitochondrial citrate utilization. J Biol Chem 273: 3740-3746, 1998.
180. Schneider BD and Leibold EA. Effects of iron regulatory protein regulation on iron homeostasis during hypoxia. Blood 102: 3404-3411, 2003.
181. Schranzhofer M, Schifrer M, Cabrera JA, Kopp S, Chiba P, Beug H, and Mullner EW. Remodeling the regulation of iron metabolism during erythroid differentiation to ensure efficient heme biosynthesis. Blood 107: 4159-4167, 2006.
182. Schroeder SE, Reddy MB, and Schalinske KL. Retinoic acid modulates hepatic iron homeostasis in rats by attenuating the RNA-binding activity of iron regulatory proteins. J Nutr 137: 2686-2690, 2007.
183. Seiser C, Teixeira S, and Kuhn LC. Interleukin-2-dependent transcriptional and post-transcriptional regulation of trans-ferrin receptor mRNA. J Biol Chem 268: 13074-13080, 1993.
184. Semenza GL. Regulation of oxygen homeostasis by hypoxia-inducible factor 1. Physiology (Bethesda) 24: 97-106, 2009.
185. Semenza GL and Wang GL. A nuclear factor induced by hypoxia via de novo protein synthesis binds to the human erythropoietin gene enhancer at a site required for tran-scriptional activation. Mol Cell Biol 12: 5447-5454, 1992.
186. Shah YM, Matsubara T, Ito S, Yim SH, and Gonzalez FJ. Intestinal hypoxia-inducible transcription factors are essential for iron absorption following iron deficiency. Cell Metab 9: 152-164, 2009.
187. Shayeghi M, Latunde-Dada GO, Oakhill JS, Laftah AH, Takeuchi K, Halliday N, Khan Y, Warley A, McCann FE, Hider RC, Frazer DM, Anderson GJ, Vulpe CD, Simpson RJ, and McKie AT. Identification of an intestinal heme transporter. Cell 122: 789-801, 2005.
188. Sheikh-Ali M, Chehade JM, and Mooradian AD. The anti-oxidant paradox in diabetes mellitus. Am J Ther. 2009 Sep 21. [Epub ahead of print]
189. Sheth S and Brittenham GM. Genetic disorders affecting proteins of iron metabolism: Clinical implications. Annu Rev Med 51: 443-464, 2000.
190. Shi R, Huang CC, Aronstam RS, Ercal N, Martin A, and Huang YW. N-acetylcysteine amide decreases oxidative stress but not cell death induced by doxorubicin in H9c2 cardiomyocytes. BMC Pharmacol 9: 7, 2009.
191. Sies H. Oxidative stress: Oxidants and antioxidants. Exp Physiol 82: 291-295, 1997.
192. Silvestri L, Pagani A, and Camaschella C. Furin-mediated release of soluble hemojuvelin: A new link between hyp-oxia and iron homeostasis. Blood 111: 924-931, 2008.
193. Smith AG, Clothier B, Robinson S, Scullion MJ, Carthew P, Edwards R, Luo J, Lim CK, and Toledano M. Interaction between iron metabolism and 2,3,7,8-tetrachlorodibenzo-p-dioxin in mice with variants of the Ahr gene: A hepatic oxidative mechanism. Mol Pharmacol 53: 52-61, 1998.
194. Smith SR, Cooperman S, Lavaute T, Tresser N, Ghosh M, Meyron-Holtz E, Land W, Ollivierre H, Jortner B, Switzer R, 3rd, Messing A, and Rouault TA. Severity of neurodegeneration correlates with compromise of iron metabolism in mice with iron regulatory protein deficiencies. Ann NY Acad Sci 1012: 65-83, 2004.
195. Starzynski RR, Goncalves AS, Muzeau F, Tyrolczyk Z, Smuda E, Drapier JC, Beaumont C, and Lipinski P. STAT5 proteins are involved in down-regulation of iron regulatory protein 1 gene expression by nitric oxide. Biochem J 400: 367-375, 2006.
196. Sterba M, Popelova O, Simunek T, Mazurova Y, Potacova A, Adamcova M, Kaiserova H, Ponka P, and Gersl V. Cardioprotective effects of a novel iron chelator, pyridoxal 2-chlorobenzoyl hydrazone, in the rabbit model of dauno-rubicin-induced cardiotoxicity. J Pharmacol Exp Ther 319: 1336-1347, 2006.
197. Tacchini L, Bianchi L, Bernelli-Zazzera A, and Cairo G. Transferrin receptor induction by hypoxia. HIF-1-mediated transcriptional activation and cell-specific post-transcrip-tional regulation. J Biol Chem 274: 24142-24146, 1999.
198. Tacchini L, Fusar Poli D, Bernelli-Zazzera A, and Cairo G. Transferrin receptor gene expression and transferrin-bound iron uptake are increased during postischemic rat liver re-perfusion. Hepatology 36: 103-111, 2002.
199. Tacchini L, GammellaE, De Ponti C, Recalcati S, and Cairo G. Role of HIF-1 and NF-kappaB transcription factors in the modulation oftransferrin receptor by inflammatory and anti-inflammatory signals. J Biol Chem 283: 20674-20686, 2008.
200. Tacchini L, Recalcati S, Bernelli-Zazzera A, and Cairo G. Induction of ferritin synthesis in ischemic-reperfused rat liver: Analysis of the molecular mechanisms. Gastro-enterology 113: 946-953, 1997.
201. Teixeira S and Kuhn LC. Post-transcriptional regulation of the transferrin receptor and 4F2 antigen heavy chain mRNA during growth activation of spleen cells. Eur J Bio-chem 202: 819-826, 1991.
202. Testa U, Kuhn L, Petrini M, Quaranta MT, Pelosi E, and Peschle C. Differential regulation of iron regulatory element-binding protein(s) in cell extracts of activated lymphocytes versus monocytes-macrophages. J Biol Chem 266: 13925-13930, 1991.
203. Theil EC. Targeting mRNA to regulate iron and oxygen metabolism. Biochem Pharmacol 59: 87-93, 2000.
204. Theil EC and Eisenstein RS. Combinatorial mRNA regulation: Iron regulatory proteins and iso-iron-responsive elements (Iso-IREs). J Biol Chem 275: 40659-40662, 2000.
205. Torti FM and Torti SV. Regulation of ferritin genes and protein. Blood 99: 3505-3516, 2002.
206. Toth I, Yuan L, Rogers JT, Boyce H, and Bridges KR. Hy-poxia alters iron-regulatory protein-1 binding capacity and modulates cellular iron homeostasis in human hepatoma and erythroleukemia cells. J Biol Chem 274: 4467-4473, 1999.
207. Tsuji Y, Ayaki H, Whitman SP, Morrow CS, Torti SV, and Torti FM. Coordinate transcriptional and translational regulation of ferritin in response to oxidative stress. Mol Cell Biol 20: 5818-5827, 2000.
208. van Helden YG, Keijer J,Knaapen AM, Heil SG, Briede JJ, van Schooten FJ, and Godschalk RW. Beta-carotene metabolites enhance inflammation-induced oxidative DNA damage in lung epithelial cells. Free Radic Biol Med 46: 299-304, 2009.
209. Vashisht AA, Zumbrennen KB, Huang X, Powers DN, Durazo A, Sun D, Bhaskaran N, Persson A, Uhlen M, Sangfelt O, Spruck C, Leibold EA, and Wohlschlegel JA. Control of iron homeostasis by an iron-regulated ubiquitin ligase. Science 326: 718-721, 2009.
210. Vecchi C, Montosi G, Zhang K, Lamberti I, Duncan SA, Kaufman RJ, and Pietrangelo A. ER stress controls iron metabolism through induction of hepcidin. Science 325: 877-880, 2009.
211. Viatte L, Grone HJ, Hentze MW, and Galy B. In vivo role(s) of the iron regulatory proteins (IRP) 1 and 2 in aseptic local inflammation. J Mol Med 87: 913-921, 2009.
212. Volz K. The functional duality of iron regulatory protein 1. Curr Opin Struct Biol 18: 106-111, 2008.
213. Walden WE, Selezneva AI, Dupuy J, Volbeda A, Fontecilla-Camps JC, Theil EC, and Volz K. Structure of dual function iron regulatory protein 1 complexed with ferritin IRE-RNA. Science 314: 1903-1908, 2006.
214. Wallander ML, Leibold EA, and Eisenstein RS. Molecular control of vertebrate iron homeostasis by iron regulatory proteins. Biochim Biophys Acta 1763: 668-689, 2006.
215. Wallander ML, Zumbrennen KB, Rodansky ES, Romney SJ, and Leibold EA. Iron-independent phosphorylation of iron regulatory protein 2 regulates ferritin during the cell cycle. J Biol Chem 283: 23589-23598, 2008.
216. Wang J, Chen G, Muckenthaler M, Galy B, Hentze MW, and Pantopoulos K. Iron-mediated degradation of IRP2, an unexpected pathway involving a 2-oxoglutarate-dependent oxygenase activity. Mol Cell Biol 24: 954-965, 2004.
217. Wang J, Fillebeen C, Chen G, Biederbick A, Lill R, and Pantopoulos K. Iron-dependent degradation of Apo-IRP1 by the ubiquitin-proteasome pathway. Mol Cell Biol 27: 2423-2430, 2007.
218. Wang W, Di X, D'Agostino RB, Jr., Torti SV, and Torti FM. Excess capacity of the iron regulatory protein system. J Biol Chem 282: 24650-24659, 2007.
219. Weiss G. Iron metabolism in the anemia of chronic disease. Biochim Biophys Acta 1790: 682-693, 2009.
220. Wessling-Resnick M. Iron imports. III. Transfer of iron from the mucosa into circulation. Am J Physiol Gastrointest Liver Physiol 290: G1-6, 2006.
221. Wingert RA, Galloway JL, Barut B, Foott H, Fraenkel P, Axe JL, Weber GJ, Dooley K, Davidson AJ, Schmid B, Paw BH, Shaw GC, Kingsley P, Palis J, Schubert H, Chen O, Kaplan J, and Zon LI. Deficiency of glutaredoxin 5 reveals Fe-S clusters are required for vertebrate haem synthesis. Nature 436: 1035-1039, 2005.
222. Wrighting DM and Andrews NC. Iron homeostasis and erythropoiesis. Curr Top Dev Biol 82: 141-167, 2008.
223. Wu KJ, Polack A, and Dalla-Favera R. Coordinated regulation of iron-controlling genes, H-ferritin and IRP2, by c-MYC. Science 283: 676-679, 1999.
224. Yamanaka K, Ishikawa H, Megumi Y, Tokunaga F, Kanie M, Rouault TA, Morishima I, Minato N, Ishimori K, and Iwai K. Identification of the ubiquitin-protein ligase that recognizes oxidized IRP2. Nat Cell Biol 5: 336-340, 2003.
225. Yu Y, Kovacevic Z, and Richardson DR. Tuning cell cycle regulation with an iron key. Cell Cycle 6: 1982-1994, 2007.
226. Zahringer J, Baliga BS, and Munro HN. Novel mechanism for translational control in regulation of ferritin synthesis by iron. Proc Natl Acad Sci USA 73: 857-861, 1976.
227. Zecca L, Youdim MB, Riederer P, Connor JR, and Crichton RR. Iron, brain ageing and neurodegenerative disorders. Nat Rev Neurosci 5: 863-873, 2004.
228. Zhang AS and Enns CA. Iron homeostasis: Recently identified proteins provide insight into novel control mechanisms. J Biol Chem 284: 711-715, 2009.
229. Zhang DL, Hughes RM, Ollivierre-Wilson H, Ghosh MC, and Rouault TA. A ferroportin transcript that lacks an iron-responsive element enables duodenal and erythroid precursor cells to evade translational repression. Cell Metab 9: 461-473, 2009.
230. Zhang F, Wang W, Tsuji Y, Torti SV, and Torti FM. Post-transcriptional modulation of iron homeostasis during p53-dependent growth arrest. J Biol Chem 283: 33911-33918, 2008.
231. Zimmer M, Ebert BL, Neil C, Brenner K, Papaioannou I, Melas A, Tolliday N, Lamb J, Pantopoulos K, Golub T, and Iliopoulos O. Small-molecule inhibitors of HIF-2a translation link its 5'UTR iron-responsive element to oxygen sensing. Mol Cell 32: 838-848, 2008.
232. Zumbrennen KB, Hanson ES, and Leibold EA. HOIL-1 is not required for iron-mediated IRP2 degradation in HEK293 cells. Biochim Biophys Acta 1783: 246-252, 2008.
233. Zumbrennen KB, Wallander ML, Romney SJ, and Leibold EA. Cysteine oxidation regulates the RNA-binding activity of iron regulatory protein 2. Mol Cell Biol 29: 2219-2229, 2009.